Platelet Rich Plasma for Patients With Recurrent Implantation Failure

EARLY_PHASE1CompletedINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

January 16, 2019

Primary Completion Date

December 20, 2023

Study Completion Date

December 20, 2023

Conditions
Infertility
Interventions
COMBINATION_PRODUCT

Platelet rich plasma

Patients will have 60ml of blood drawn. Platelet rich plasma will be obtained by placing the blood in the Arteriocyte Magellan device. 0.5ml of Platelet rich plasma will be placed into the uterus at least 48 hours prior to embryo transfer.

COMBINATION_PRODUCT

Placebo

Patients will have 60ml of blood drawn. 0.5ml of embryo culture media (the placebo) will be placed into the uterus at least 48 hours prior to embryo transfer.

Trial Locations (1)

94087

Stanford Fertility and Reproductive Health, Sunnyvale

All Listed Sponsors
lead

Stanford University

OTHER

NCT03379649 - Platelet Rich Plasma for Patients With Recurrent Implantation Failure | Biotech Hunter | Biotech Hunter